Produção Científica do Departamento de Otorrinolaringologia do HC/FMUSP 2025.

Para acessar o trabalho completo, por favor, entre em contato com: biblioteca@forl.org.br

SETEMBRO

Electrolarynx Prototype With Adjustable Period Perturbation and Fundamental Frequency: Acoustic Analysis and Perceptual Preferences.

Davatz GC, Yamasaki R, Sanchez RF, Hachiya A, Tsuji DH, Montagnoli AN.

J Voice. 2025 Sep 16:S0892-1997(25)00278-4. doi: 10.1016/j.jvoice.2025.07.015.

Fator de Impacto: 2.4

Rhinosinusitis: Evidence and experience – 2024.

Romano FR, Anselmo-Lima WT, Kosugi EM, Sakano E, Valera FCP, Lessa M, Roithmann R, Pignatari S, Felippu AWD, Meotti CD, Barreto CC, Solé D, Goudouris ES, Kuschnir FC, Pinna FR, Serpa FS, Matsumoto GRLL, Freire GSM, Mello JF Junior, Boechat JL, Balsalobre Filho LL, Miyake MM, Nakanishi M, Fornazieri MA, Toro MDC, Tepedino MS, Rubini NPM, Mion OG, Dolci RLL, Voegels RL, Guimarães RE, Dortas SD Junior, Bezerra TFP, Dinarte VRP, Tamashiro E, Piltcher OB.

Braz J Otorhinolaryngol. 2025 Sep-Oct;91(5):101595. doi: 10.1016/j.bjorl.2025.101595.

Fator de Impacto: 1.8

Key Performance Indicators Applied in Medicine.

Bento RF, Gândara MER, Penteado SP.

Int Arch Otorhinolaryngol. 2025 Sep 26;29(3):1-10. doi: 10.1055/s-0045-1809426.

Fator de Impacto: 1.1

it Possible to Reuse the University of Pennsylvania Smell Identification Test (UPSIT ®)? The “2 Zs” Protocol.

Asada LO, Andrade JDS, Bueno LC, Voegels RL, Pinna FR, Fornazieri MA. Is

Int Arch Otorhinolaryngol. 2025 Sep 26;29(3):1-5. doi: 10.1055/s-0045-1810003.

Fator de Impacto: 1.1

AGOSTO

Study of Arytenoid Adduction Under Laryngotracheal Intubation in Excised Human Larynges.

d’Avila DV, Perazzo PSL, d’Avila JS, Reis FP, Sennes LU, Tsuji DH.

J Voice. 2025 Aug 4:S0892-1997(25)00281-4. doi: 10.1016/j.jvoice.2025.07.018.

Fator de Impacto: Fator de Impacto: 2.4

Reactivation of cutaneous leishmaniasis in the context of non-HIV immunosuppression: a literature analysis.

de Souza RM, Tuon FF, Dantas LR, Imamura R, Funari AP, Celeste BJ, Amato VS.

Trans R Soc Trop Med Hyg. 2025 Aug 8;119(8):922-925. doi: 10.1093/trstmh/traf038.

Fator de Impacto: 1.5

JULHO

Efficacy of the adjunctive use of photobiomodulation therapy in olfactory disorders in post-COVID-19 patients: A randomized controlled trial.

Oliveira PC, Correia LO, Lopes NMD, Suassuna GR, Doty RL, Pinna FR, Voegels RL, Fornazieri MA.

Braz J Otorhinolaryngol. 2025 Jul-Aug;91(4):101583. doi: 10.1016/j.bjorl.2025.101583.

Fator de Impacto: 1.8

JUNHO

A Novel Treatment for Convex Lateral Crura: The Inverted Spanning Suture.

Caropreso CA, Porpino R, Neves JC, Ichiba G, Hirotani P, Carvalho V, Souza MC, Rodrigues JL.

Facial Plast Surg. 2025 Jun;41(3):300-306. doi: 10.1055/a-2308-3649.

Fator de Impacto: 1.4

Prevalence of tonsillar human papillomavirus infection in low-risk individuals without cancer.

Silva JBD, Silva AO, Sacoman LRR, Matos LL, Frizzarini R, Moyses RA, Levi JE.

Einstein (Sao Paulo). 2025 Jun 16;23:eAO1715. doi: 10.31744/einstein_journal/2025AO1715.

Fator de Impacto: 0.9

MAIO

The Fusion Sling-Revisiting the Nasal Tip Suspensory Anatomy.

Neves JC, Rijo-Cedeño J, Teixeira Rodrigues JL, Filgueiras H, Sa Sodre H, Siqueira S, Jacomo A, Kaminskyi E, García-Berrocal JR.

Facial Plast Surg Clin North Am. 2025 May;33(2):143-157. doi: 10.1016/j.fsc.2025.02.001.

Fator de Impacto: 1.9

The pitfalls of positional dizziness: Not everything is crystal.

Mangia LRL, Mezzalira R, Bittar RSM.

Braz J Otorhinolaryngol. 2025 May-Jun;91(3):101575. doi: 10.1016/j.bjorl.2025.101575.

Fator de Impacto: 1.8

Otoneurological evaluation: definitions and scientific evidence of bedside assessment and complementary exams. Outcomes of the II Brazilian Forum of Otoneurology.

Salmito MC, Morganti LOG, Venosa AR, Ganança FF, Ganança MM, Mezzalira R, Bittar RSM, Ramos BF, Dias CM, Real DM, Gonçalves DU, Zuma E Maia FC, Lopes KC, Santos MAO, Machado PLF, Albertino RS, Cal RVR, Dorigueto RS, Silva RC, Carvalho RCB, Albertino S.

Braz J Otorhinolaryngol. 2025 May-Jun;91(3):101594. doi: 10.1016/j.bjorl.2025.101594.

Fator de Impacto: 1.8

Rapid Maxilla Expansion Technique in Patients With Severe Hemophilia Type A: Treatment Protocol.

Pereira CM, Santarelli RJ, Vasconcellos FAF, Santos CMDS, Pinna FR, Voegels RL, Peres MPSM, Machado GG, Okazaki E, Junior LAVS, Villaça PR, Zambon CE.

Spec Care Dentist. 2025 May-Jun;45(3):e70064. doi: 10.1111/scd.70064.

Fator de Impacto: 1.0

Modified palatal flap via soft palate for skull base reconstruction.

Pezato R, Stamm AC, Costacurta ASD, Baptista CHAB, Fujita RR, Dassi CS, Voegels RL, Thamboo A, Tepedino MS.

Einstein (Sao Paulo). 2025 May 2;23:eAO1247. doi: 10.31744/einstein_journal/2025AO1247.

Fator de Impacto: 0.9

ABRIL

Upper airway microcirculation remodeling in obstructive sleep apnea is not driven by endothelial activation.

Fahl K, Mauad T, de Brito JM, Costa NSX, Dantas DAS, de Souza HP, Sampaio RO, Sennes LU, Cahali MB.

Sci Rep. 2025 Apr 17;15(1):13355. doi: 10.1038/s41598-025-98190-x.

Fator de Impacto: 3.9

The international expert consensus on management of external auditory canal carcinoma.

Zhou P, de Brito R, Cui Y, Lloyd S, Kunst H, Kutz JW, Mani N, Moon IS, Mostafa BE, Nabuurs C, Rao SCP, Xie B, Zhang Y, Dai C.

Eur Arch Otorhinolaryngol. 2025 Apr;282(4):1677-1691. doi: 10.1007/s00405-024-09033-w.

Fator de Impacto: 2.2

Myoneurectomy for Adductor Spasmodic Dysphonia: Long-Term Outcomes, Complications, and Recurrence.

Tsuji DH, Hachiya A, Imamura R, Sennes LU.

Laryngoscope. 2025 Apr;135(4):1444-1450. doi: 10.1002/lary.31904.

Fator de Impacto: 2.0

Blood IgE and Eosinophils are not Reliable Predictors of Nasal Tissue Eosinophils in Chronic Rhinosinusitis with Nasal Polyposis.

Fan J, Daniels W, Pascual A, Ryu C, Sarafan M, Tepedino MS, Voegels RL, Fornazieri MA, Sin D, Pezato R, Thamboo A.

Int Arch Otorhinolaryngol. 2025 Apr 15;29(2):1-5. doi: 10.1055/s-0044-1801316.

Fator de Impacto: 1.1

Isotretinoin in Thick-Skin Rhinoplasty: A Review.

Dias RPP, Rodrigues JLT, Jabour MSD, Albuquerque ROE, Friedrich HA, Westphalen MS, Caropreso CA.

Int Arch Otorhinolaryngol. 2025 Apr 22;29(2):1-6. doi: 10.1055/s-0044-1801319.

Fator de Impacto: 1.1

MARÇO

Translabyrinthine versus Retrosigmoid Approach for Vestibular Schwannoma: A Systematic Review and An Updated Meta-Analysis.

Gibbon FL, Lindner RJ, Vial ADM, da Silva GG, Palavani LB, Semione G, Worm PV, Isolan GR, da Silva VAR, Bento RF, Friedman RA, Lavinsky J.

Otolaryngol Head Neck Surg. 2025 Mar;172(3):774-786. doi: 10.1002/ohn.1031.

Fator de Impacto: 2.5

Electronic cigarettes: “wolves in sheep’s clothing”.

Chong-Silva DC, Sant’Anna MFBP, Riedi CA, Sant’Anna CC, Ribeiro JD, Vieira LMN, Pinto LA, Terse-Ramos R, Morgan MAP, Godinho RN, di Francesco RC, da Silva CAM, Urrutia-Pereira M, Lotufo JPB, Silva LR, Solé D.

J Pediatr (Rio J). 2025 Mar-Apr;101(2):122-132. doi: 10.1016/j.jped.2024.06.015.

Fator de Impacto: 2.5

Effect of active middle ear implant on auditory speech perception in individuals with ear malformation.

Catisquini EAT, Teixeira MM, Zampronio CDP, Oliveira JRM, Mondelli MFCG, Lourençone LFM, Brito Neto RV.

Codas. 2025 Mar 31;37(3):e20240032. doi: 10.1590/2317-1782/e20240032pt.

Fator de Impacto: 0.8

FEVEREIRO

Transient radiation-induced severe obstructive sleep apnea.

Palma VM, Silva POT, Formigoni GGS, Sennes LU, Cahali MB.

J Clin Sleep Med. 2025 Feb 1;21(2):427-429. doi: 10.5664/jcsm.11382.

Fator de Impacto: 2.9

Otorhinolaryngology Foundation: Three Decades of Excellence in Education, Research, and Scientific Advancement.

Bento RF, Montefusco AM, Ribeiro GVG, Lowndes ALL, Fozzati AA.

Int Arch Otorhinolaryngol. 2025 Feb 10;29(1):1-13. doi: 10.1055/s-0044-1801808.

Fator de Impacto: 1.1

The Near Point of Convergence in Patients with Vestibular Migraine.

Maia FCZE, Ramos BF, Bittar RSM, Cal RVR, Luís LA, Albernaz PLM.

Int Arch Otorhinolaryngol. 2025 Feb 5;29(1):1-4. doi: 10.1055/s-0044-1791643.

Fator de Impacto: 1.1

JANEIRO

Disparities among Different Countries in Access for Diagnosis and Treatment of Pediatric Sensorineural Hearing Loss.

DeVries J, Birman CS, Loundon N, MacAskil M, Távora NM, Tsuji RK, Cheung L, Kari E, Carvalho D.

Otol Neurotol. 2025 Jan 1;46(1):e1-e8. doi: 10.1097/MAO.0000000000004382.

Fator de Impacto: 2.0

V Brazilian Consensus on Rhinitis – 2024.

Solé D, Kuschnir FC, Pastorino AC, Constantino CF, Galvão C, Chong E Silva DC, Baptistella E, Goudouris ES, Sakano E, Ejzenbaum F, Matsumoto FY, Mizoguchi FM, Aarestrup FM, Wandalsen GF, Chong Neto HJ, Brito de Oliveira JV, Lubianca Neto JF, Rizzo MCV, Silva Chavarria MLF, Urrutia-Pereira M, Filho NAR, de Paula Motta Rubini N, Mion O, Piltcher OB, Ramos RT, Francesco RD, Roithmann R, Anselmo-Lima WT, Romano FR, de Mello Júnior JF.

Braz J Otorhinolaryngol. 2025 Jan-Feb;91(1):101500. doi: 10.1016/j.bjorl.2024.101500.

Fator de Impacto: 1.8

Brazilian Society of Otology task force – cochlear implant ‒ recommendations based on strength of evidence.

Tsuji RK, Hamerschmidt R, Lavinsky J, Felix F, Silva VAR.

Braz J Otorhinolaryngol. 2025 Jan-Feb;91(1):101512. doi: 10.1016/j.bjorl.2024.101512.

Fator de Impacto: 1.8

Brazilian Society of Otology task force – single sided deafness – recommendations based on strength of evidence.

Tsuji RK, Hamerschmidt R, Lavinsky J, Felix F, Silva VAR.

Braz J Otorhinolaryngol. 2025 Jan-Feb;91(1):101514. doi: 10.1016/j.bjorl.2024.101514.

Fator de Impacto: 1.8

Neuromodulatory Treatment for Dizziness and Chronic Neurological Dysfunction in an Elderly Patient Using Radio Electric Asymmetric Conveyer (REAC) Neuro Psycho Physical Optimization (NPPO) Gamma Brain Wave Optimization (BWO-G): A Case Report.

Rinaldi S, Modestto’ V, Rinaldi A, Bittar R, Oiticica J, Fontani V.

Cureus. 2025 Jan 15;17(1):e77518. doi: 10.7759/cureus.77518.

Fator de Impacto: 1.3

Feasibility of Self-Programming of the Speech Processor Via Remote Assistant Fitting in Experienced Cochlear Implant Users.

Samuel-Sierra PA, Goffi-Gomez MVS, Magalhães ATM, Bento RF, Tsuji RK.

Int Arch Otorhinolaryngol. 2025 Jan 27;29(1):1-10. doi: 10.1055/s-0044-1789194.

Fator de Impacto: 1.1

Adilson Montefusco

Bibliotecário

Departamento de Otorrinolaringologia – HC-FMUSP

Fundação Otorrinolaringologia

+55 11 3062 4097